Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
US Department of Justice
Cantor Fitzgerald
Boehringer Ingelheim

Generated: June 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 090816

« Back to Dashboard

NDA 090816 describes BIVALIRUDIN, which is a drug marketed by Accord Hlthcare, Apotex Inc, Dr Reddys Labs Ltd, Fresenius Kabi Usa, Hospira Inc, Mylan Institutional, and Baxter Hlthcare Corp, and is included in eight NDAs. It is available from five suppliers. Additional details are available on the BIVALIRUDIN profile page.

The generic ingredient in BIVALIRUDIN is bivalirudin. There are thirteen drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the bivalirudin profile page.
Summary for 090816
Applicant:Hospira Inc
Formulation / Manufacturing:see details
Pharmacology for NDA: 090816
Mechanism of ActionThrombin Inhibitors
Suppliers and Packaging for NDA: 090816
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BIVALIRUDIN bivalirudin INJECTABLE;INTRAVENOUS 090816 ANDA Hospira, Inc. 0409-8300 N 0409-8300-10
BIVALIRUDIN bivalirudin INJECTABLE;INTRAVENOUS 090816 ANDA Hospira, Inc. 0409-8300 N 0409-8300-15

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INTRAVENOUSStrength250MG/VIAL
Approval Date:Jul 14, 2015TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Daiichi Sankyo
Johnson and Johnson
Boehringer Ingelheim
Federal Trade Commission
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.